Cargando…
Proteinuria and glomerular injury associated with the anti-angiogenesis drug Vargatef™
Autores principales: | Manjunath, Veena, Moeckel, Gilbert W., Mahnensmith, Rex, Perazella, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421682/ https://www.ncbi.nlm.nih.gov/pubmed/25984216 http://dx.doi.org/10.1093/ndtplus/sfr064 |
Ejemplares similares
-
Long-term high-dose cholecalciferol in patients with heavy proteinuria
por: Singer, Richard F.
Publicado: (2011) -
Proteinuria in Diabetes
por: Thomas, Stephen, et al.
Publicado: (2000) -
New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond
por: Gori, Bruno, et al.
Publicado: (2011) -
Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury
por: Zhou, Han, et al.
Publicado: (2017) -
Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis
por: Kanaguchi, Yasuhiko, et al.
Publicado: (2011)